Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    16946036 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma
Conditions: Primary Mediastinal B-cell Lymphoma;   Diffuse, Large B-cell Lymphoma;   Diffuse Large B-Cell Lymphoma Transformed From Follicular Lymphoma;   Mantle Cell
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: Anti-CD19-CAR PBL
2 Recruiting Immunotherapy Using Precision T Cells Specific to Personalized Neo-antigen for the Treatment of Advanced Malignant Tumor of Biliary Tract
Condition: Advanced Biliary Tract Malignant Tumor
Interventions: Drug: Gemcitabine;   Biological: Dendritic cell-precision T cell for neo-antigen combined with gemcitabine treatment

Study has passed its completion date and status has not been verified in more than two years.